Skip to main content
. 2016 Aug 30;12(5):3195–3198. doi: 10.3892/ol.2016.5065

Figure 2.

Figure 2.

Association between SOX2 expression and prognosis of non-small cell lung carcinoma. Survival analysis revealed that the prognosis of patients of the high expression group was better (P=0.008) and the 5-year survival rate was higher (high vs. low: 55.5 vs. 35.3%).